3Rein MS,Barbieri RL,Friedman AJ. Progesterone:a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol, 1995,172(1 Pt 1):14
4Murphy AA, Kettel LM, Morales AJ, et al. Regression of uterine leiomyomta in response to the antiprogesterone RU 486. J Clin Endocrinol Meteb, 1993,76(2):513
5Murphy AA, Morales AJ, Kettel LM, et al. Regression of uterine leiomyomata to the antiprogesterone RU 486: doseresponse effect. Fertil Steril, 1995,64(1):187
6Reinsch RC, Murphy AA, Morales AJ, et al. The effects of RU486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study. Am J Obstet Gynecol, 1994, 170(6):1 623
3Irving M. Spitz. Mifepristone: where do we come from and where are we going?: Clinical development over a quarter of a century [J]. Contraception, 2010, 82(5):442-452.
4Li Yiu-Tai, Kuo Tsung-Cheng, Chu Yi-Chih, et al. Mifepristone and Misoprostol Induced Abortion with A Large Myomatous Uterus [J]. Taiwan Residents Journal of Obstetrics and Gynecology, 2005, 44 (2): 175-176.
5Steon H. Eisinger MD, FACOG, Thomas Bonfiglio MD, Kevin Fiscrlla MD, MPH, et al. Twelve-month safety and efficacy of low-dose mifepristone for uterine myomas [J]. Journal of Minimally Invasive Gynecology, 2005,12(3): 227-233.
6De Leo V, Morgante G. Uterine fibromas and the hormonal pattern: the therapeutic consideration [J]. Minerva Gineeol,1996,48:533-538.
